Atlas Trials

Transfer of Genetically Engineered Lymphocytes in Melanoma Patients

Clinical trial NCT01586403 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01586403
Sponsor
Loyola University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Melanoma
Start date
2012-07-01
Primary completion
2028-09-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.